references
The Drugs for Neglected Diseases initiative (DNDi) is a patient-needs driven, not-for-profit research and development (R&D) organization that develops safe, effective, and affordable treatments for the millions of people across the world affected by neglected diseases, notably human African trypanosomiasis (sleeping sickness), leishmaniasis, Chagas disease, filariasis, paediatric HIV, mycetoma, and hepatitis C.
DNDi’s primary objective: > Deliver 16 to 18 new treatments by 2023 for targeted neglected diseases and establish a robust R&D portfolio that addresses patients’ treatment needs In doing this, DNDi has two further objectives: > Use and strengthen capacities in disease-endemic countries via project implementation > Raise awareness about the need to develop new drugs for neglected diseases and advocate for increased public responsibility
15 Chemin Louis-Dunant 1202 Geneva Switzerland Tel: +41 22 906 9230 Fax: +41 22 906 9231 dndi@dndi.org www.dndi.org
Facebook.com/dndi.org Linkedin.com/company/dndi Twitter.com/dndi Youtube.com/dndiconnect
DNDi AFRICA
Tetezi Towers, 3rd Floor George Padmore Road, Kilimani P. O. Box 21936-00505 Nairobi Kenya Tel: +254 20 3995 000
DNDi INDIA
PHD House, 3rd Floor 4/2 Siri Institutional Area New Delhi 110016 India Tel: +91 11 4550 1795
DNDi LATIN AMERICA
Rua Santa Heloisa 5 Jardim Botânico Rio de Janeiro – RJ 22460-080 Brazil Tel: +55 21 2215 2941 www.dndial.org
DNDi NORTH AMERICA
40 Wall Street, 24th Floor New York, NY 10005 USA Tel: +1 646 616 8680 www.dndina.org
DNDi DRC
Avenue Milambo, n°4 Quartier Socimat Commune de la Gombe Kinshasa Democratic Republic of the Congo Tel: +243 81 659 79 95
DNDi JAPAN
704 Nishi-Shinjuku KF Bldg 8-14-24 Nishi-Shinjuku, Shinjuku-ku Tokyo 160-0023 Japan Tel.: +81 3 4550 1199 Fax: +81 3 5937 6977 www.dndijapan.org
DNDi SOUTH EAST ASIA
L10-7, Menara Sentral Vista, 150, Jln Sultan Abdul Samad Brickfields 50470 Kuala Lumpur Malaysia Tel: +60 3 2716 4159
Subscribe to DNDi’s newsletter: www.dndi.org/newsletter
